Annual report
6960.TEDINET S100YLF7
Period2025-04-01 → 2026-03-31
Filed2026-06-26
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥139.7bn | 2025-04-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥139.0bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥140.3bn | 2023-04-01 → 2024-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥134.6bn | 2022-04-01 → 2023-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥132.1bn | 2021-04-01 → 2022-03-31v | Cons. | Net sales (5-year summary) |
| Operating income | ¥26.6bn | 2025-04-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | ¥25.9bn | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | ¥27.3bn | 2025-04-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥26.6bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥27.0bn | 2023-04-01 → 2024-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥25.1bn | 2022-04-01 → 2023-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥23.4bn | 2021-04-01 → 2022-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥27.0bn | 2025-04-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥27.1bn | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥18.8bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥18.6bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥18.7bn | 2023-04-01 → 2024-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥17.3bn | 2022-04-01 → 2023-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥16.2bn | 2021-04-01 → 2022-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥18.8bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | ¥18.6bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥225.4bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥221.3bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥209.1bn | at 2024-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥206.9bn | at 2023-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥195.5bn | at 2022-03-31v | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥36.6bn | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥39.7bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥188.8bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥181.7bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥169.0bn | at 2024-03-31v | Cons. | Net assets |
| Net assets / equity | ¥163.0bn | at 2023-03-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥149.9bn | at 2022-03-31v | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥65.7bn | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥72.4bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥60.7bn | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥67.3bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥57.2bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥64.9bn | at 2023-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥61.0bn | at 2022-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥29.3bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥33.0bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥23.9bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥23.1bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥23.1bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥18.7bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥17.1bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥14.8bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥14.2bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥10.8bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥17.4bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥5.8bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥17.1bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥5.6bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥4.8bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥683.41 | 2025-04-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥645.41 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥622.44 | 2023-04-01 → 2024-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥571.25 | 2022-04-01 → 2023-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥536.19 | 2021-04-01 → 2022-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥6,988.36 | at 2026-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥6,301.01 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥5,863.22 | at 2024-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥5,390.09 | at 2023-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥4,954.7 | at 2022-03-31v | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 83.8% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 82.1% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 80.8% | at 2024-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.8% | at 2023-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.7% | at 2022-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 10.1% | 2025-04-01 → 2026-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.6% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.3% | 2023-04-01 → 2024-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.0% | 2022-04-01 → 2023-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.3% | 2021-04-01 → 2022-03-31v | Cons. | Rate of return on equity (5-year summary) |
| Employees | 3,497 | at 2026-03-31 | Cons. | Number of employees |
| Employees | 3,465 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 3,443 | at 2024-03-31v | Cons. | Number of employees |
| Employees | 3,382 | at 2023-03-31v | Cons. | Number of employees |
| Employees | 3,348 | at 2022-03-31v | Cons. | Number of employees |
| Revenue | ¥89.9bn | 2025-04-01 → 2026-03-31 | Standalone | Net sales |
| Revenue | ¥87.1bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥87.0bn | 2023-04-01 → 2024-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥82.3bn | 2022-04-01 → 2023-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥82.5bn | 2021-04-01 → 2022-03-31v | Standalone | Net sales (5-year summary) |
| Operating income | ¥17.6bn | 2025-04-01 → 2026-03-31 | Standalone | Operating income |
| Operating income | ¥15.4bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Ordinary income | ¥24.5bn | 2025-04-01 → 2026-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥22.8bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥21.2bn | 2023-04-01 → 2024-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥18.5bn | 2022-04-01 → 2023-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥18.0bn | 2021-04-01 → 2022-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥32.0bn | 2025-04-01 → 2026-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥23.4bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Net income | ¥27.0bn | 2025-04-01 → 2026-03-31 | Standalone | Profit loss |
| Net income | ¥18.7bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥17.1bn | 2023-04-01 → 2024-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥14.8bn | 2022-04-01 → 2023-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥14.4bn | 2021-04-01 → 2022-03-31v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥200.4bn | at 2026-03-31 | Standalone | Assets |
| Total assets | ¥193.2bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥177.6bn | at 2024-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥176.0bn | at 2023-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥163.5bn | at 2022-03-31v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥43.1bn | at 2026-03-31 | Standalone | Liabilities |
| Total liabilities | ¥50.4bn | at 2025-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥157.3bn | at 2026-03-31 | Standalone | Net assets |
| Net assets / equity | ¥142.9bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥130.7bn | at 2024-03-31v | Standalone | Net assets |
| Net assets / equity | ¥127.2bn | at 2023-03-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥117.1bn | at 2022-03-31v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥44.2bn | at 2026-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥50.3bn | at 2025-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥980.21 | 2025-04-01 → 2026-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥647.55 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥567.96 | 2023-04-01 → 2024-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥489.27 | 2022-04-01 → 2023-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥477.6 | 2021-04-01 → 2022-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥230 | 2025-04-01 → 2026-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥195 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥185 | 2023-04-01 → 2024-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥240 | 2022-04-01 → 2023-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥305 | 2021-04-01 → 2022-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥5,822.2 | at 2026-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥4,955.47 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥4,534.7 | at 2024-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥4,204.87 | at 2023-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,871.21 | at 2022-03-31v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 78.5% | at 2026-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.9% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.6% | at 2024-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.3% | at 2023-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 71.6% | at 2022-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 18.0% | 2025-04-01 → 2026-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 13.6% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 13.2% | 2023-04-01 → 2024-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.1% | 2022-04-01 → 2023-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.9% | 2021-04-01 → 2022-03-31v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 37,747,000 | at 2026-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 37,747,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 37,747,000 | at 2024-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 39,176,000 | at 2023-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 19,588,000 | at 2022-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 786 | at 2026-03-31 | Standalone | Number of employees |
| Employees | 719 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 699 | at 2024-03-31v | Standalone | Number of employees |
| Employees | 690 | at 2023-03-31v | Standalone | Number of employees |
| Employees | 669 | at 2022-03-31v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 64
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment assets | at 2026-03-31 | ¥107.3bn |
| Consumables And Other Productsreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥3.2bn |
| Consumables And Other Productsreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥897m |
| Consumables And Other Productsreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥39.8bn |
| Consumables And Other Productsreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥39.8bn |
| Consumables And Other Productsreportable segment | segment assets | at 2026-03-31 | ¥26.9bn |
| Consumables And Other Productsreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥6.6bn |
| Medical Treatment Equipmentreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥18.1bn |
| Medical Treatment Equipmentreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥10.2bn |
| Medical Treatment Equipmentreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥63.7bn |
| Medical Treatment Equipmentreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥63.7bn |
| Medical Treatment Equipmentreportable segment | segment assets | at 2026-03-31 | ¥65.4bn |
| Medical Treatment Equipmentreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥13.9bn |
| Patient Monitoring Equipmentreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥737m |
| Patient Monitoring Equipmentreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥210m |
| Patient Monitoring Equipmentreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥9.3bn |
| Patient Monitoring Equipmentreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥9.3bn |
| Patient Monitoring Equipmentreportable segment | segment assets | at 2026-03-31 | ¥6.9bn |
| Patient Monitoring Equipmentreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥1.7bn |
| Physiological Diagnostic Equipmentreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥2.1bn |
| Physiological Diagnostic Equipmentreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥608m |
| Physiological Diagnostic Equipmentreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥26.9bn |
| Physiological Diagnostic Equipmentreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥26.9bn |
| Physiological Diagnostic Equipmentreportable segment | segment assets | at 2026-03-31 | ¥18.9bn |
| Physiological Diagnostic Equipmentreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥4.4bn |
| —segment total | employees | at 2026-03-31 | 2717 pure |
| Total Of Reportable Segments And Otherssegment total | capex | 2025-04-01 → 2026-03-31 | ¥24.2bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2025-04-01 → 2026-03-31 | ¥11.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2026-03-31 | ¥139.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2026-03-31 | ¥139.7bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2026-03-31 | ¥118.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2026-03-31 | ¥26.6bn |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | ¥108.9bn |
| Consumables And Other Productsreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥1.2bn |
| Consumables And Other Productsreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥723m |
| Consumables And Other Productsreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥38.7bn |
| Consumables And Other Productsreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥38.7bn |
| Consumables And Other Productsreportable segment | segment assets | at 2025-03-31 | ¥26.1bn |
| Consumables And Other Productsreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥6.3bn |
| Medical Treatment Equipmentreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥12.2bn |
| Medical Treatment Equipmentreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥9.1bn |
| Medical Treatment Equipmentreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥62.0bn |
| Medical Treatment Equipmentreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥62.0bn |
| Medical Treatment Equipmentreportable segment | segment assets | at 2025-03-31 | ¥59.1bn |
| Medical Treatment Equipmentreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥13.1bn |
| Patient Monitoring Equipmentreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥304m |
| Patient Monitoring Equipmentreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥182m |
| Patient Monitoring Equipmentreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥9.8bn |
| Patient Monitoring Equipmentreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥9.8bn |
| Patient Monitoring Equipmentreportable segment | segment assets | at 2025-03-31 | ¥7.5bn |
| Patient Monitoring Equipmentreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥1.7bn |
| Physiological Diagnostic Equipmentreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥887m |
| Physiological Diagnostic Equipmentreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥533m |
| Physiological Diagnostic Equipmentreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥28.5bn |
| Physiological Diagnostic Equipmentreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥28.5bn |
| Physiological Diagnostic Equipmentreportable segment | segment assets | at 2025-03-31 | ¥19.8bn |
| Physiological Diagnostic Equipmentreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥4.8bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2024-04-01 → 2025-03-31 | ¥14.5bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-04-01 → 2025-03-31 | ¥10.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2025-03-31 | ¥139.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2025-03-31 | ¥139.0bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2025-03-31 | ¥112.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2025-03-31 | ¥25.9bn |
| —segment total | employees | at 2026-03-31 | 627 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,709
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)有限責任 あずさ監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)梶原 崇宏 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)嶋瀬 統之 | |
| Audit opinion consolidated (text) | FilingDateInstant | Text · Plus | |
| Key audit matters consolidated (text) | FilingDateInstant | Text · Plus | |
| Overview kam consolidated (text) | FilingDateInstant | Text · Plus | |
| Short description kam consolidated | FilingDateInstant_Row1Member | Original text (Japanese)余剰在庫の評価の合理性 | |
| Description including reason kam consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Reference kam consolidated | FilingDateInstant_Row1Member | Original text (Japanese)【注記事項】（重要な会計上の見積り）１．余剰在庫の評価 | |
| Auditors response kam consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Other information consolidated (text) | FilingDateInstant | Text · Plus | |
| Fee related information consolidated (text) | FilingDateInstant | Text · Plus | |
| Independent auditors report non consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)有限責任 あずさ監査法人 | |
| Cpa1 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)梶原 崇宏 | |
| Cpa2 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)嶋瀬 統之 | |
| Audit opinion non consolidated (text) | FilingDateInstant | Text · Plus | |
| Key audit matters non consolidated (text) | FilingDateInstant | Text · Plus | |
| Overview kam non consolidated (text) | FilingDateInstant | Text · Plus | |
| Short description kam non consolidated | FilingDateInstant_Row1Member | Original text (Japanese)余剰在庫の評価の合理性 | |
| Same as kam for consolidated fskam non consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Other information non consolidated (text) | FilingDateInstant | Text · Plus | |
| Fee related information non consolidated (text) | FilingDateInstant | Text · Plus | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior4YearDuration | 132098000000 | JPY |
| Net sales (5-year summary) | Prior3YearDuration | 134648000000 | JPY |
| Net sales (5-year summary) | Prior2YearDuration | 140323000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 139007000000 | JPY |
| Net sales (5-year summary) | CurrentYearDuration | 139697000000 | JPY |
| Ordinary income loss (5-year summary) | Prior4YearDuration | 23422000000 | JPY |
| Ordinary income loss (5-year summary) | Prior3YearDuration | 25081000000 | JPY |
| Ordinary income loss (5-year summary) | Prior2YearDuration | 26990000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 26633000000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYearDuration | 27341000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior4YearDuration | 16216000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior3YearDuration | 17278000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior2YearDuration | 18693000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 18605000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYearDuration | 18790000000 | JPY |
| Comprehensive income (5-year summary) | Prior4YearDuration | 16432000000 | JPY |
| Comprehensive income (5-year summary) | Prior3YearDuration | 18439000000 | JPY |
| Comprehensive income (5-year summary) | Prior2YearDuration | 22699000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 18160000000 | JPY |
| Comprehensive income (5-year summary) | CurrentYearDuration | 24238000000 | JPY |
| Net assets (5-year summary) | Prior4YearInstant | 149857000000 | JPY |
| Net assets (5-year summary) | Prior3YearInstant | 163047000000 | JPY |
| Net assets (5-year summary) | Prior2YearInstant | 169008000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 181652000000 | JPY |
| Net assets (5-year summary) | CurrentYearInstant | 188796000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |